Packard C - Search Results

1

Lorimer AR, Packard C. Lorimer AR, et al. Among authors: packard c. Practitioner. 1993 May;237(1526):446-9. Practitioner. 1993. PMID: 8346168 No abstract available.

2

Metabolism of apolipoprotein B in primary moderate hypercholesterolaemia: effects of acipimox and cholestyramine therapy.

Gaw A, Packard CJ, Lindsay GM, Collins SM, Lorimer AR, Shepherd J. Gaw A, et al. Among authors: packard cj. Eur J Med Res. 1995 Oct 16;1(1):38-48. Eur J Med Res. 1995. PMID: 9392692

3

Isolated CDH risk factors.

Cole F, Thistlethwaite J, Lorimer AR, Packard C. Cole F, et al. Among authors: packard c. Practitioner. 1993 Dec;237(1533):886-9. Practitioner. 1993. PMID: 8108318 No abstract available.

4

Probucol reduces plasma lipid peroxides in man.

Paterson JR, Rumley AG, Oldroyd KG, Tait GW, Smellie WS, Packard CJ, Shepherd J, Lorimer AR. Paterson JR, et al. Among authors: packard cj. Atherosclerosis. 1992 Nov;97(1):63-6. doi: 10.1016/0021-9150(92)90051-h. Atherosclerosis. 1992. PMID: 1445494

5

[Antilipemic agents and postprandial lipidemia].

Shepherd J, Simpson H, Williamson CM, Pringle S, MacLean J, Lorimer AR, Packard CJ. Shepherd J, et al. Among authors: packard cj. Klin Wochenschr. 1990;68 Suppl 22:83-8. Klin Wochenschr. 1990. PMID: 2087086 German. No abstract available.

6

Postprandial lipemia, fenofibrate and coronary artery disease.

Simpson HS, Williamson CM, Olivecrona T, Pringle S, Maclean J, Lorimer AR, Bonnefous F, Bogaievsky Y, Packard CJ, Shepherd J. Simpson HS, et al. Among authors: packard cj. Atherosclerosis. 1990 Dec;85(2-3):193-202. doi: 10.1016/0021-9150(90)90111-u. Atherosclerosis. 1990. PMID: 2102083

7

Acipimox in combination with low dose cholestyramine for the treatment of type II hyperlipidaemia.

Series JJ, Gaw A, Kilday C, Bedford DK, Lorimer AR, Packard CJ, Shepherd J. Series JJ, et al. Among authors: packard cj. Br J Clin Pharmacol. 1990 Jul;30(1):49-54. doi: 10.1111/j.1365-2125.1990.tb03742.x. Br J Clin Pharmacol. 1990. PMID: 2390432 Free PMC article. Clinical Trial.

8

Effect of combined therapy with bezafibrate and cholestyramine on low-density lipoprotein metabolism in type IIa hypercholesterolemia.

Series JJ, Caslake MJ, Kilday C, Cruickshank A, Demant T, Lorimer AR, Packard CJ, Shepherd J. Series JJ, et al. Among authors: packard cj. Metabolism. 1989 Feb;38(2):153-8. doi: 10.1016/0026-0495(89)90255-2. Metabolism. 1989. PMID: 2643751 Clinical Trial.

9

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillop JH, Packard CJ. Shepherd J, et al. Among authors: packard cj. N Engl J Med. 1995 Nov 16;333(20):1301-7. doi: 10.1056/NEJM199511163332001. N Engl J Med. 1995. PMID: 7566020 Free article. Clinical Trial.

10

Overproduction of small very low density lipoproteins (Sf 20-60) in moderate hypercholesterolemia: relationships between apolipoprotein B kinetics and plasma lipoproteins.

Gaw A, Packard CJ, Lindsay GM, Griffin BA, Caslake MJ, Lorimer AR, Shepherd J. Gaw A, et al. Among authors: packard cj. J Lipid Res. 1995 Jan;36(1):158-71. J Lipid Res. 1995. PMID: 7706941 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

507 results

Search Page

Filters